JF
HUMA icon

Jump Financial’s Humacyte HUMA Stock Holding History

Jump Financial’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-93,763
Closed -$474K – 1780
2024
Q4 		$474K Sell
93,763
-233,859
-71% -$1.16M 0.01% 1100
2024
Q3 		$1.78M Buy
327,622
+167,325
+104% +$1.1M 0.04% 568
2024
Q2 		$769K Buy
+160,297
New +$834K 0.02% 943
2022
Q3 		– Sell
-15,100
Closed -$48K – 1747
2022
Q2 		$48K Buy
+15,100
New +$84K ﹤0.01% 1504

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Jump Financial's HUMA Position: Q1 2025 in Review

Jump Financial sold out of Humacyte (HUMA) in Q1 2025, closing a stake of 93,763 shares — an estimated $474K sold.

Jump Financial first reported a position in HUMA in Q2 2022 and held it in 4 quarters. The position peaked at $1.78M in Q3 2024. 168 funds tracked by Wall St. Rank hold HUMA as of Q1 2025.

  • Jump Financial reported no remaining Humacyte position as of Q1 2025 after selling out during the quarter.
  • Jump Financial sold 93,763 Humacyte shares in Q1 2025, an estimated $474K.
  • Jump Financial first reported a position in Humacyte in Q2 2022 and held it in 4 quarters.
  • Jump Financial's Humacyte position peaked at $1.78M in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Humacyte as of Q1 2025.

Based on Jump Financial's 13F filing for Q1 2025, filed 14 May 2025.